Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jiuzhou Pharmaceutical Co. Ltd.

Zhejiang Jiuzhou Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,301
1,282
1,437
1,638
1,693
1,840
Cost of Goods Sold (COGS) incl. D&A
922
952
1,013
1,287
1,244
1,317
Gross Income
379
330
424
351
449
523
SG&A Expense
170
170
227
232
247
300
EBIT
198
151
183
111
187
214
Unusual Expense
11
15
15
1
-
25
Non Operating Income/Expense
8
9
20
16
15
7
Interest Expense
19
20
15
8
2
5
Pretax Income
199
160
235
132
173
191
Income Tax
32
20
31
21
27
37
Equity in Affiliates
-
1
3
5
1
2
Consolidated Net Income
167
137
200
111
147
156
Net Income
166
133
200
111
148
157
Net Income After Extraordinaries
166
133
200
111
148
157
Net Income Available to Common
166
133
200
111
148
157
EPS (Basic)
0.22
0.22
0.27
0.14
0.18
0.20
Basic Shares Outstanding
748
607
750
798
798
801
EPS (Diluted)
0.22
0.22
0.27
0.14
0.19
0.20
Diluted Shares Outstanding
748
607
750
798
798
801
EBITDA
211
223
293
264
355
390
Other Operating Expense
12
8
14
8
15
9
Non-Operating Interest Income
2
5
6
6
3
7
Minority Interest Expense
-
4
-
-
1
1

About Zhejiang Jiuzhou Pharmaceutical Co.

View Profile
Address
99 Waisha Road
Taizhou Zhejiang 318000
China
Employees -
Website http://www.jiuzhoupharma.com
Updated 07/08/2019
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. engages in the production and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst and lithium battery materials. Its products include Carbamazepine, Oxcarbazepine, Duloxetine, Amprolium, Sulphadimethoxine, Sulphadimethoxine Sodium, Sulfasalazine, Bezafibrate, Ketoprofen, Gliclazide, Imipenem, Meropenem, Duloxetine and Pregabalin. The company was founded by Xuan De Hua in 1973 and is headquartered in Taizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.